Large genomic aberrations in MSH2 and MLH1 genes are frequent in Chinese colorectal cancer
Ming Zhu(AbbVie (United States)), Yaping Wang(Huashan Hospital), Yuanying Zhang(University of Science and Technology Beijing), Jintian Li(South China Normal University), Xiaomei Zhang(Peking University), Xiaorong Liu(Hunan University of Traditional Chinese Medicine), Xiaoliu Wu(Jiangsu Cancer Hospital), Waltraut Friedl(University Hospital Bonn), Peter Propping(University of Bonn)
Cited by 14
Related Papers
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k
A Potassium Channel Mutation in Neonatal Human Epilepsy
|Science|1998|1.1k
Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
|Journal of Clinical Oncology|2017|752
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study
|The Lancet Oncology|2017|327